Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Cancer Lett. 2012 Nov 28;340(2):10.1016/j.canlet.2012.10.040. doi: 10.1016/j.canlet.2012.10.040

Table 1.

Comparison of the targeted bisulfite sequencing methods

Method BSPP SHBS-seq ACBS-seq Bisulfite-Patch
PCR
Microdroplet
PCR
Reference [47] [48] [49] [51] [52] [58] [60] [62]
Capture probes/primer ssDNA ssDNA ssDNA Biotinylated RNA Biotinylated RNA ssDNA Partial dsDNA ssDNA
Probe/primer size 150 bp 150 bp 150 bp 160 bp 120 bp 60 bp 40–50 bp 20–30 bp
Number of probes/primers 30,000 9,552 330,000 51,551 n/a 240,000 94 pairs 3,500 pairs
Probe/primer manufacturer Agilent Agilent Agilent Agilent Agilent Agilent Sigma RainDance
Capture method Annealing, extension and circularization Annealing, extension and circularization Annealing, extension and circularization Hybridization in solution Hybridization in solution Hybridization on array Annealing, ligation, and PCR Microdroplet PCR
Amount of input DNA 200 ng bisulfite-treated 1 µg bisulfite-treated 200 ng bisulfite-treated 20–30 µg native 2–3 µg native 20 µg bisulfite-treated and amplified 250 ng bisulfite-treated 2 µg bisulfite-treated
Bisulfite treatment Pre-capture Pre-capture Pre-capture Post-capture Pre-capture Pre-capture Pre-capture Pre-capture
Sequencing platform Illumina Illumina Illumina Illumina Illumina Illumina 454 Illumina
Target size 2.1Mb n/a 34Mb 8.2Mb 38Mb 258.9kb 25.5kb 1.35Mb
Number of targets 10,582 9552 140,749 51,551 n/a 324 94 3,500
Target features CGI, ENCODE, (TSS±1000bp) ENCODE regions DMRs, CTCF, DNase I sites CGI, TSS Exon CGI Promoter Promoter (TSS±1000bp)
Targets covered n/a 68% (>10 reads) n/a 85–88% (>10 reads) 90% (>10 reads) ~92% 100% 99%
On-target rate (%) n/a n/a 96% 77–84% 71–75% 6–12% 90% 90%
Number of CpG 66,000 6,400 500,0000 0.9–1 million n/a 25,044 n/a 77,674
Coverage per CpG n/a n/a n/a 86–146 (mean) 58–73 95–105 (median) 444 (median) >100 (97% of CpGs)
Reproducibility (r) 0.97 0.965 0.97–98 0.94 n/a n/a 0.91 n/a
Advantages Highly specific and reproducible, require lower amount of input DNA Flexible probe design; easy to scale up to target large regions Use bisulfite-treated and amplified DNA Require lower amount of DNA, use regular PCR primers Highly multiplex PCR, low PCR bias
Disadvantages Expensive probes, complex probe design Capture small amount of DNA; challenges in bisulfite treatment Low capture specificity, require specific instruments Uncertainty about scale-up in throughput Require specific instruments.